Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients (Q72665999)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6176821%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6176821%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

C. E. Jones

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6176821

21 August 2023

P. R. Dyken

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6176821

21 August 2023

P. R. Huttenlocher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6176821

21 August 2023

J. T. Jabbour

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6176821

21 August 2023

K. W. Maxwell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6176821

21 August 2023

language of work or name

English

0 references

publication date

1 May 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6176821%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

8 May 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6176821

full work available at URL

21 August 2023

https://api.elsevier.com/content/article/PII:S0140673682920979?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92097-9

https://api.elsevier.com/content/article/PII:S0140673682920979?httpAccept=text/plain

21 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92097-9

21 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6176821%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6176821%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

8280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6176821%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1034-1037

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6176821%20AND%20SRC:MED&resulttype=core&format=json

Immunopathologic observations in subacute sclerosing panencephalitis.

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Measles as an index of immunological function.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Immunological Features in a Case of Subacute Sclerosing Panencephalitis Treated with Transfer Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Amantadine therapy in subacute sclerosing panencephalitis: A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Review of 38 cases of subacute sclerosing panencephalitis: effect of amantadine on the natural course of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Anti-herpesvirus action of isoprinosine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Effect of Isoprinosine Against Influenza and Some Other Viruses Causing Respiratory Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Suppressor cell activity after isoprinosine treatment of lymphocytes from normal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Isoprinosine as an Immunopotentiator

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Differntiation and Regulation of Lymphocyte Populations: Evidence for Immunopotentiator-Induced T Cell Recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Isoprinosine in subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Inosiplex in the Treatment of Subacute Sclerosing Panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Unusual features in a Case Diagnosed as Subacute Sclerosing Panencephalitis (SSPE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Subacute sclerosing panencephalitis in the Middle East: report of 99 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Subacute sclerosing panencephalitis: an epidemiologic study in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Epidemiology of subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992097-9

7 January 2021

Medical registers

37

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92097-9

Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG)

21 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92097-9

Surveillance of subacute sclerosing panencephalitis

21 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92097-9

Evaluation of survival data and two new rank order statistics arising in its consideration

21 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92097-9

21 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6176821%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference